(S)-5-(1-(2,3-Dimethylphenyl)ethyl)-1H-imidazole hydrochloride, 95.0%, 250mg

TERT-BUTYL 4-(6-NITRO-1H-INDOL-3-YL)-5,6-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE, 97.0%, 5g

4-Methylpiperazin-2-one, 95.0%, 25g

(S)-1-Isopropyl-3-methyl-piperazine dihydrochloride, 95.0%, 100mg

2-Bromo-4-fluorobenzotrifluoride, 98.0%, 5g

Ethyl 4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidine-7-carboxylate, 95.0%, 250mg

1,3,5-Tri(1H-imidazol-1-yl)benzene>95.0%(T)(HPLC)1g

2-(4-bromo-1H-pyrazol-1-yl)-N-methylacetamide, 95.0%, 1g

Methyl 2-methoxy-4-nitrobenzoate, 98%, 5g

2-BROMO-5-METHOXY-4-METHYLBENZOIC ACID, 95.0%, 10g

1,2-Bis(diphenylphosphino)benzene>98.0%(GC)1g

2,3-Difluoro-1-isopropoxy-4-methylbenzene, 98%, 1g

Etanolamina, mínimo 99%, para síntesis, 2,5 l, envase de plástico.